stars 1 stars 2 stars 3

Biofabri is a Spanish biopharmaceutical company founded in 2008 based on a legacy of more than 70 years' experience in the pharmaceutical industry. Its main activity focuses on the research&development and industrial production of vaccines for human use and the contract manufacturing and distribution (CDMO) of pharmaceutical products. Our most advanced project is a vaccine against Tuberculosis (at phase Ib), that is being developed in collaboration with the University of Zaragoza, Pasteur Institute and TB Vaccine Initiative. We count with a valuable infrastructure and knowledge to address biotech projects from a laboratory stage to a large scale production. Biofabri is a company of Zendal group, a bioparmecutical group focsed on vaccines and biotechnology.

Biofabri Questions

The Biofabri annual revenue was $9.5 million in 2026.

Esteban Rodriguez is the CEO de Biofabri and Zendal of Biofabri.

11 people are employed at Biofabri.

The NAICS codes for Biofabri are [3254, 32, 325, 32541].

The SIC codes for Biofabri are [28, 283].

Top Biofabri Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users